Largest Drug Manufacturers - General Companies by Market Cap
The Drug Manufacturers - General sector has 85 publicly listed stocks with a combined market cap of $6.82 Trillion. Eli Lilly and Company leads the sector with a market cap of $865.47 Billion. This ranking covers all Drug Manufacturers - General stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$6.82 Trillion
Companies Listed
85
Largest Company
Eli Lilly and …
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Eli Lilly and Company
NYSE:LLY |
$865.47 Billion | $865.47 Billion | USA | $966.99 | +1.95% | +0.38% | 72.33 Million |
| 2 |
Eli Lilly and Company
SA:LILY34 |
$853.51 Billion | R$4.35 Trillion | Brazil | R$153.70 | +0.70% | -0.16% | 250.45K |
| 3 |
Johnson & Johnson
NYSE:JNJ |
$533.49 Billion | $533.49 Billion | USA | $221.43 | +0.05% | -2.54% | 166.77 Million |
| 4 |
AbbVie Inc
NYSE:ABBV |
$358.55 Billion | $358.55 Billion | USA | $202.78 | +0.61% | -1.85% | 135.85 Million |
| 5 |
AstraZeneca PLC
MX:AZNN |
$290.50 Billion | MX$5.05 Trillion | Mexico | MX$1628.00 | +1.25% | -4.81% | 6.50K |
| 6 |
AstraZeneca PLC
NASDAQ:AZN |
$281.93 Billion | $281.93 Billion | USA | $181.86 | -0.54% | -1.56% | 44.44 Million |
| 7 |
Novartis AG ADR
NYSE:NVS |
$281.41 Billion | $281.41 Billion | USA | $147.48 | +0.11% | -3.02% | 34.68 Million |
| 8 |
Roche Holding AG
SW:ROG |
$279.33 Billion | CHF220.94 Billion | Switzerland | CHF320.70 | +0.79% | -8.76% | 28.40 Million |
| 9 |
Merck & Company Inc
NYSE:MRK |
$276.20 Billion | $276.20 Billion | USA | $111.28 | -0.09% | -0.78% | 220.93 Million |
| 10 |
Novartis AG
MX:NVSN |
$275.74 Billion | MX$4.79 Trillion | Mexico | MX$2511.00 | +0.04% | -3.01% | 13.82K |
| 11 |
Roche Holding AG
SW:ROP |
$254.60 Billion | CHF201.38 Billion | Switzerland | CHF319.40 | +1.30% | +0.31% | 20.99 Million |
| 12 |
AstraZeneca PLC
F:ZEGA |
$252.57 Billion | €216.04 Billion | Germany | €75.50 | -3.82% | -2.58% | 3.45K |
| 13 |
Novartis AG
SW:NOVN |
$241.30 Billion | CHF190.86 Billion | Switzerland | CHF113.70 | +0.30% | -1.90% | 60.66 Million |
| 14 |
Amgen Inc
NASDAQ:AMGN |
$177.65 Billion | $177.65 Billion | USA | $329.59 | -0.64% | -0.07% | 61.74 Million |
| 15 |
Gilead Sciences Inc
NASDAQ:GILD |
$165.66 Billion | $165.66 Billion | USA | $133.52 | +1.67% | +1.42% | 135.93 Million |
| 16 |
Novo Nordisk A/S
CO:NOVO-B |
$158.26 Billion | Dkr1.01 Trillion | Denmark | Dkr300.00 | +3.34% | +7.91% | 144.38 Million |
| 17 |
Pfizer Inc
SA:PFIZ34 |
$147.67 Billion | R$752.56 Billion | Brazil | R$33.09 | -0.78% | -2.25% | 179.03K |
| 18 |
Pfizer Inc
NYSE:PFE |
$146.75 Billion | $146.75 Billion | USA | $25.81 | +0.51% | -1.97% | 805.36 Million |
| 19 |
Bristol-Myers Squibb Company
NYSE:BMY |
$113.33 Billion | $113.33 Billion | USA | $55.67 | -0.87% | -4.38% | 222.24 Million |
| 20 |
Sanofi
MX:SNYN |
$111.20 Billion | MX$1.93 Trillion | Mexico | MX$800.08 | -5.32% | -6.53% | 7.46K |
| 21 |
GlaxoSmithKline PLC ADR
NYSE:GSK |
$111.15 Billion | $111.15 Billion | USA | $55.63 | -0.13% | -3.77% | 93.36 Million |
| 22 |
Sanofi
F:SNW2 |
$103.93 Billion | €88.90 Billion | Germany | €36.60 | -0.54% | -7.11% | 254.00 |
| 23 |
GSK PLC SP. ADR/2 NEW
F:GS70 |
$101.34 Billion | €86.68 Billion | Germany | €47.20 | +0.00% | -3.28% | 120.00 |
| 24 |
GlaxoSmithKline plc
MX:GSKN |
$100.12 Billion | MX$1.74 Trillion | Mexico | MX$867.00 | -8.49% | -14.39% | 1.06K |
| 25 |
Sanofi SA
PA:SAN |
$95.70 Billion | €81.86 Billion | France | €73.22 | +0.16% | -8.27% | 58.01 Million |
| 26 |
Roche Holding AG
SW:RO |
$44.00 Billion | CHF34.80 Billion | Switzerland | CHF326.20 | +0.99% | -0.12% | 689.91K |
| 27 |
Bayer AG NA
XETRA:BAYN |
$42.59 Billion | €36.43 Billion | Germany | €37.08 | +0.27% | -2.55% | 58.47 Million |
| 28 |
Biogen Inc
NASDAQ:BIIB |
$27.74 Billion | $27.74 Billion | USA | $197.95 | +2.33% | +5.82% | 26.74 Million |
| 29 |
ASTELLAS PHARMA UNSP.ADR
F:YPHA |
$19.55 Billion | €16.72 Billion | Germany | €12.90 | +0.00% | -3.73% | 2.40K |
| 30 |
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SHG:600436 |
$12.44 Billion | CN¥85.01 Billion | China | CN¥140.90 | -0.20% | +1.18% | 61.27 Million |
| 31 |
CSPC PHARMACEUT.GR. ADR4
F:CVGU |
$11.04 Billion | €9.44 Billion | Germany | €3.52 | +0.00% | -6.38% | 45.00 |
| 32 |
CSPC Pharmaceutical Group Limited
F:CVG |
$10.18 Billion | €8.71 Billion | Germany | €0.88 | +0.00% | -1.20% | 1.83K |
| 33 |
Orion Oyj B
HE:ORNBV |
$8.48 Billion | €7.25 Billion | Finland | €67.20 | -1.97% | -2.18% | 4.09 Million |
| 34 |
ORION CORP.B UNSP.ADR 1/2
F:OFK0 |
$8.31 Billion | €7.10 Billion | Germany | €36.20 | -1.09% | -0.55% | 40.00 |
| 35 |
Sichuan Kelun Pharmaceutical Co Ltd
SHE:002422 |
$7.76 Billion | CN¥53.04 Billion | China | CN¥33.19 | -1.34% | +1.81% | 443.67 Million |
| 36 |
GlaxoSmithKline Pharmaceuticals Limited
NSE:GLAXO |
$4.46 Billion | Rs412.71 Billion | India | Rs2436.20 | -1.64% | +4.27% | 1.64 Million |
| 37 |
Grifols S.A.
MC:GRF |
$4.36 Billion | €3.73 Billion | Spain | €8.83 | -1.23% | -1.45% | 62.80 Million |
| 38 |
GRIFOLS ADR 1/2/EO-50
F:G0F |
$4.21 Billion | €3.60 Billion | Germany | €4.26 | -2.74% | -1.84% | 192.00 |
| 39 |
Virbac SA
PA:VIRP |
$3.01 Billion | €2.58 Billion | France | €352.00 | -3.43% | -5.25% | 97.17K |
| 40 |
AstraZeneca PLC
LSE:AZN |
$2.55 Billion | GBX20.93 Trillion | UK | GBX13502.00 | +1.18% | -3.20% | 51.60 Million |
| 41 |
Orion Oyj A
HE:ORNAV |
$2.49 Billion | €2.13 Billion | Finland | €66.90 | -2.34% | -1.76% | 241.15K |
| 42 |
Pfizer Limited
NSE:PFIZER |
$2.41 Billion | Rs223.04 Billion | India | Rs4875.40 | +1.17% | +3.50% | 373.32K |
| 43 |
Kalbe Farma Tbk PT
JK:KLBF |
$2.36 Billion | Rp40.33 Trillion | Indonesia | Rp890.00 | -3.26% | +2.89% | 1.38 Billion |
| 44 |
Aurora Optoelectronics Co Ltd
SHG:600666 |
$2.30 Billion | CN¥15.74 Billion | China | CN¥5.72 | -2.22% | +3.25% | 11.45 Billion |
| 45 |
Organon & Co
NYSE:OGN |
$2.11 Billion | $2.11 Billion | USA | $13.33 | -0.15% | +0.30% | 405.10 Million |
| 46 |
Grifols S.A
F:G0FB |
$2.01 Billion | €1.72 Billion | Germany | €6.65 | -1.48% | -1.48% | 324.00 |
| 47 |
Yifan Xinfu Pharmaceutical Co Ltd
SHE:002019 |
$2.01 Billion | CN¥13.71 Billion | China | CN¥11.27 | +1.08% | +0.09% | 434.61 Million |
| 48 |
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SHE:300357 |
$1.99 Billion | CN¥13.57 Billion | China | CN¥25.92 | +2.98% | -0.04% | 262.44 Million |
| 49 |
Cosmo Pharmaceuticals N.V
F:C43 |
$1.63 Billion | €1.39 Billion | Germany | €81.40 | +1.12% | -9.45% | 1.48K |
| 50 |
Zhejiang Jolly Pharmaceutical Co Ltd
SHE:300181 |
$1.55 Billion | CN¥10.60 Billion | China | CN¥15.12 | -0.66% | -0.66% | 261.62 Million |
| 51 |
COSMO Pharmaceuticals SA
SW:COPN |
$1.52 Billion | CHF1.20 Billion | Switzerland | CHF74.60 | +1.91% | -9.02% | 1.39 Million |
| 52 |
GuangYuYuan Chinese Herbal Medicine Co Ltd
SHG:600771 |
$1.17 Billion | CN¥8.02 Billion | China | CN¥16.39 | -0.91% | -3.19% | 162.41 Million |
| 53 |
SANOFI CONS HEALTHC IND L
NSE:SANOFICONR |
$1.16 Billion | Rs107.09 Billion | India | Rs4649.90 | -2.47% | -2.39% | 224.26K |
| 54 |
NanJing Pharmaceutical Co Ltd
SHG:600713 |
$1.03 Billion | CN¥7.04 Billion | China | CN¥5.38 | +0.56% | -0.92% | 1.27 Billion |
| 55 |
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.
SHE:301096 |
$1.02 Billion | CN¥6.97 Billion | China | CN¥63.82 | +5.52% | +13.00% | 74.81 Million |
| 56 |
Chongqing Lummy Pharmaceutical
SHE:300006 |
$1.02 Billion | CN¥6.95 Billion | China | CN¥6.58 | +4.94% | +4.78% | 1.81 Billion |
| 57 |
Hunan Jingfeng Pharmaceutical
SHE:000908 |
$916.62 Million | CN¥6.26 Billion | China | CN¥7.12 | -1.39% | -4.56% | 472.09 Million |
| 58 |
GlaxoSmithKline PLC
LSE:GSK |
$901.44 Million | GBX7.41 Trillion | UK | GBX1844.50 | +0.08% | -4.36% | 133.28 Million |
| 59 |
Zhejiang Int'L Group Co Ltd
SHE:000411 |
$872.14 Million | CN¥5.96 Billion | China | CN¥11.42 | +5.94% | +8.56% | 123.53 Million |
| 60 |
Sanofi India Limited
NSE:SANOFI |
$813.73 Million | Rs75.24 Billion | India | Rs3267.10 | -1.91% | -4.11% | 942.92K |
| 61 |
Hangzhou Minsheng Healthcare Co Ltd
SHE:301507 |
$783.15 Million | CN¥5.35 Billion | China | CN¥15.01 | +0.94% | +3.95% | 84.62 Million |
| 62 |
Shandong Keyuan Pharmaceutical Co. Ltd. A
SHE:301281 |
$646.05 Million | CN¥4.41 Billion | China | CN¥40.77 | +0.82% | +4.86% | 102.37 Million |
| 63 |
SENORES PHARMACEUTICALS L
NSE:SENORES |
$477.03 Million | Rs44.11 Billion | India | Rs957.80 | -0.80% | +6.52% | 7.19 Million |
| 64 |
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd A
SHG:600613 |
$411.02 Million | CN¥2.81 Billion | China | CN¥5.86 | +0.51% | -0.34% | 501.61 Million |
| 65 |
Zhejiang Zhenyuan Share Co Ltd
SHE:000705 |
$399.45 Million | CN¥2.73 Billion | China | CN¥8.17 | -0.97% | -6.84% | 179.42 Million |
| 66 |
Hubei Guangji Pharmaceutical Co Ltd
SHE:000952 |
$391.21 Million | CN¥2.67 Billion | China | CN¥7.71 | +1.58% | +4.47% | 256.82 Million |
| 67 |
Dimed S.A. Distribuidora de Medicamentos
SA:PNVL3 |
$382.19 Million | R$1.95 Billion | Brazil | R$13.05 | -3.97% | -3.83% | 17.12 Million |
| 68 |
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
SHG:600671 |
$355.69 Million | CN¥2.43 Billion | China | CN¥19.96 | -0.60% | +2.46% | 59.49 Million |
| 69 |
Guangdong Jiaying Pharmaceutical Co Ltd
SHE:002198 |
$353.50 Million | CN¥2.42 Billion | China | CN¥4.76 | -4.99% | -26.32% | 415.89 Million |
| 70 |
Amarin Corporation PLC
NASDAQ:AMRN |
$303.32 Million | $303.32 Million | USA | $15.02 | -0.20% | +6.75% | 1.92 Million |
| 71 |
Chorokbaem Healthcare Co Ltd
KO:118000 |
$242.13 Million | ₩357.29 Billion | Korea | ₩2080.00 | +0.00% | +808.30% | 25.77 Million |
| 72 |
NGL Fine-Chem Limited
NSE:NGLFINE |
$152.30 Million | Rs14.08 Billion | India | Rs2279.50 | -2.61% | +2.94% | 259.61K |
| 73 |
TTK Healthcare Limited
NSE:TTKHLTCARE |
$140.12 Million | Rs12.96 Billion | India | Rs916.90 | -1.07% | +1.42% | 133.02K |
| 74 |
Daishin Balance No.6 Special Purpose Acquisition Co. Ltd
KQ:307750 |
$121.22 Million | ₩178.88 Billion | Korea | ₩3565.00 | -4.68% | -10.88% | 14.03 Million |
| 75 |
PharmGen Science Inc
KO:004720 |
$56.87 Million | ₩83.93 Billion | Korea | ₩3830.00 | -4.49% | -8.26% | 2.57 Million |
| 76 |
Scilex Holding Company
NASDAQ:SCLX |
$48.53 Million | $48.53 Million | USA | $6.90 | -11.76% | -34.78% | 2.21 Million |
| 77 |
MIRA Pharmaceuticals, Inc. Common Stock
NASDAQ:MIRA |
$41.46 Million | $41.46 Million | USA | $0.99 | +0.30% | -4.81% | 3.20 Million |
| 78 |
Singbao International Co Ltd
TWO:6130 |
$33.01 Million | NT$1.05 Billion | Taiwan | NT$23.65 | -0.21% | -3.07% | 7.57 Million |
| 79 |
BCWORLD PHARM. Co. Ltd
KQ:200780 |
$28.61 Million | ₩42.22 Billion | Korea | ₩4130.00 | -5.17% | -7.50% | 501.15K |
| 80 |
Korean Drug Co. Ltd
KQ:014570 |
$28.27 Million | ₩41.71 Billion | Korea | ₩3855.00 | -3.87% | -9.19% | 545.99K |
| 81 |
Nasus Pharma Ltd.
NYSE MKT:NSRX |
$27.17 Million | $27.17 Million | USA | $3.04 | -3.49% | +10.55% | 2.90 Million |
| 82 |
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd B
SHG:900904 |
$25.30 Million | $25.30 Million | China | $0.46 | -0.86% | -2.33% | 3.03 Million |
| 83 |
Yung Zip Chemical Ind Co Ltd
TWO:4102 |
$23.76 Million | NT$754.26 Million | Taiwan | NT$17.80 | +0.56% | -2.47% | 1.60 Million |
| 84 |
Lipidor Ab
ST:LIPI |
$18.82 Million | Skr174.88 Million | Sweden | Skr0.22 | +0.00% | +0.00% | 194.23 Million |
| 85 |
Firebrick Pharma Ltd
AU:FRE |
$8.93 Million | AU$12.62 Million | Australia | AU$0.05 | -3.85% | -5.66% | 3.17 Million |
Track real-time market capitalization of largest public companies in the Drug Manufacturers - General industry. Compare marketcap, analyze stock performance, and discover leading drug manufacturers - general corporations. View all industries